Tadalafil for veterans with chronic obstructive pulmonary disease—pulmonary hypertension: A multicenter, placebo‐controlled randomized trial
2022 · Pulmonary Circulation · 14 citations
https://doi.org/10.1002/pul2.12043
S
Shelley Shapiro
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
47
Papers
2.1K
Citations
15
h-index
19
i10-index
Shelley Shapiro is an academic researcher from University of Oxford. The author has contributed to research in topics: Pulmonary Hypertension Research and Treatments & Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis & Transplantation: Methods and Outcomes. The author has an h-index of 15, co-authored 40 publications.
Papers by this author
worksTreprostinil to Reverse Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis as a Bridge to Single-Lung Transplantation
2009 · The Journal of Heart and Lung Transplantation · 9 citations
https://doi.org/10.1016/j.healun.2009.05.017
Significance of autoimmune disease in severe pulmonary hypertension complicating extensive pulmonary fibrosis: a prospective cohort study
2021 · Pulmonary Circulation · 8 citations
https://doi.org/10.1177/20458940211011329
The ALPHA phase 1 study: pulmonary ArteriaL hypertension treated with CardiosPHere-Derived allogeneic stem cells
2023 · EBioMedicine · 7 citations
https://doi.org/10.1016/j.ebiom.2023.104900
Capillary Proliferation in Systemic‐Sclerosis‐Related Pulmonary Fibrosis: Association with Pulmonary Hypertension
2019 · ACR Open Rheumatology · 5 citations
https://doi.org/10.1002/acr2.1003
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat